How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

580 results for

Postpartum Endometritis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Menopause Chapter 3: Clinical Issues

no anatomic pathology. In addition to perimenopausal anovulation, irregular bleeding can be caused by anovulation associated with thyroid abnormalities, hyperprolactinemia, or polycystic ovarian syndrome. Anatomic causes of abnormal uterine bleeding (AUB) include polyps, fibroids, endometritis, endometrial hyperplasia, and cancer. Evaluation of AUB may include the following laboratory tests, based on the clinical situation: complete blood count, pregnancy test, coagulation profile, sexually transmitted (...) the menopause transition. A history of premenstrual syndrome or postpartum depression is a strong risk factor for mood symptoms at midlife. Life stressors are common at midlife and often coincide with the menopause transition. Recommendations for Clinical Care Healthcare providers should screen for psychological symptoms at midlife and treat psychological problems when indicated or provide appropriate referrals. (Level II) Mild depressive symptoms respond well to psychotherapy. Moderate or severe depressive

2014 The North American Menopause Society

182. Quality Improvement Guidelines for Uterine Artery Embolization for Symptomatic Leiomyomata

agonistusebeforetheperformanceofUAEmaycomplicatetheprocedure by induction of vasospasm, such a sequential therapeutic protocol has been employed successfully and has been reported in the literature (8). Transcatheter embolization of the uterine arteries for treatment of uterine leiomyomata was ?rst reported by Ravina et al in 1995 (9). The procedurewasbasedonestablishedtechniquesfortreatingpelvicbleeding related to trauma or gynecologic emergencies, such as postpartum hemorrhage. Goodwin et al (10)reportedthe ?rst experience in the United States (...) or bulk- related pain, bloating, urinary frequency, or constipation, without additional therapy. Dysmenorrhea is de?ned as painful menstruation. Endometritis is de?ned as in?ammation of the inner lining of the uterus (endometrium) after UAE, which manifests as pelvic pain, watery vaginal discharge, fever, and/or leukocytosis, and can occur days to weeks after the procedure. Etiologies include infectious and noninfectious causes. Leiomyomainfectionisde?nedasbacterialinfectionofoneormore leiomyomata

2014 Society of Interventional Radiology

183. Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement

restriction (FGR) h Delivery Cesearean section/operative deliveries Small or large for gestational age (SGA/LGA), i preterm delivery (PTD), j anomalies detected by obstetrical screening Postpartum and neonatal/infancy Thromboembolism, postpartum depression, Lactation rates Anomalies detected after birth, neonatal intensive care unit admission, length of stay a A death of male or female parent or fetus/infant participating in trials should be reported. b OHSS (ovarian hyperstimulation syndrome

2014 Society for Assisted Reproductive Technology

184. Clinical practice guideline for care in pregnancy and puerperium

the possibility of puerperal depression: “During the last month, have you often worried because you felt down, depressed or hopeless?” “During the last month, have you been worried because you often felt that you had little interest in activities and that these did not provide you any pleasure?”34 CLINICAL PRACTICE GUIDELINES IN THE SNS Weak We suggest not continuing with the diagnosis of postpartum depression if she says ‘no’ to the previous questions. Strong The Edinburgh Postnatal Depression Scale (EPDS (...) of the evidence 344 B) Grading strength of the recommendations 345 Appendix 3. Tables 347 Appendix 4. Abbreviations 354 Appendix 5. Edinburgh Postnatal Depression Scale (EPDS) 355 Validated Spanish version (adapted from Garcia-Esteve 2003) 355 Bibliography 357CPG FOR CARE IN PREGNANCY AND PUERPERIUM 7 Presentation Documenting the variability in clinical practice, analyse its causes and adopt strategies aimed at eliminating it, have proven to be initiatives that promote safe and effective decision-making

2014 GuiaSalud

186. Prophylactic antibiotics before cord clamping in cesarean delivery: a systematic review. Full Text available with Trip Pro

Prophylactic antibiotics before cord clamping in cesarean delivery: a systematic review. The number of clinical trials investigating the optimal timing of prophylactic antibiotics in cesarean section has increased rapidly over the last few years. We conducted a systematic review to inform up-to-date evidence-based guidelines to prevent postpartum infectious morbidity in the mother and rule out any safety issues related to antepartum antibiotic exposure in infants.Four bibliographic databases (...) % (relative risk 0.72, 95% confidence interval 0.56-0.92, nine studies, 4342 women, high quality of evidence) less likely to show infectious morbidity as compared with those who received antibiotics after cord clamping. The risk of endomyometritis and/or endometritis was reduced by 43% (relative risk 0.57, 95% confidence interval 0.40-0.82, 13 studies, 6250 women, high quality of evidence) and the risk of wound infection by 38% (relative risk 0.62, 95% confidence interval 0.47-0.81, 14 studies, 6450 women

2017 Acta Obstetricia et Gynecologica Scandinavica

187. Committee Opinion No. 712 Summary: Intrapartum Management of Intraamniotic Infection. (Abstract)

will be noted among term patients in labor. Intraamniotic infection can be associated with acute neonatal morbidity, including neonatal pneumonia, meningitis, sepsis, and death. Maternal morbidity from intraamniotic infection also can be significant, and may include dysfunctional labor requiring increased intervention, postpartum uterine atony with hemorrhage, endometritis, peritonitis, sepsis, adult respiratory distress syndrome and, rarely, death. Recognition of intrapartum intraamniotic infection

2017 Obstetrics and Gynecology

188. Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection. (Abstract)

will be noted among term patients in labor. Intraamniotic infection can be associated with acute neonatal morbidity, including neonatal pneumonia, meningitis, sepsis, and death. Maternal morbidity from intraamniotic infection also can be significant, and may include dysfunctional labor requiring increased intervention, postpartum uterine atony with hemorrhage, endometritis, peritonitis, sepsis, adult respiratory distress syndrome and, rarely, death. Recognition of intrapartum intraamniotic infection

2017 Obstetrics and Gynecology

189. Intra-uterine Cleaning During Cesarean Section

more than 100 beats per minute (bpm). A diagnosis of endomyometritis will be criteria for initiating treatment with antibiotics. Secondary Outcome Measures : Primary postpartum hemorrhage [ Time Frame: Within 6 weeks ] Post partum hemorrhage [ Time Frame: Within 6 weeks after delivery ] Mean surgical time [ Time Frame: Immediately post cesarean ] Calculated blood loss [ Time Frame: Within 6 weeks post delivery ] Hospital length of stay [ Time Frame: Participants will be followed for the duration (...) will have their uterine cavities left alone after complete delivery of the placenta. The placenta will be inspected after delivery to make sure it is complete, including the membranes. Outcome Measures Go to Primary Outcome Measures : Postpartum endometritis [ Time Frame: Within weeks ] Endomyometritis after delivery [ Time Frame: Within 6 weeks after delivery ] Endomyometritis will be diagnosed by the presence of two or more of the following: abnormally tender uterus on examination, temperature more

2017 Clinical Trials

190. Phytotherapy in Streptococcus agalactiae: An Overview of the Medicinal Plants Effective against Streptococcus agalactiae Full Text available with Trip Pro

Phytotherapy in Streptococcus agalactiae: An Overview of the Medicinal Plants Effective against Streptococcus agalactiae Streptococcus agalactiae is a spherical and Gram-positive bacterium that causes postpartum sepsis, endometritis, chorioamnionitis and premature delivery in pregnant women. The use of herbs and natural ingredients for the treatment of various disorders has been common. The present review is a report on the medicinal plants with anti-Streptococcus agalactiae effects

2017 Journal of clinical and diagnostic research : JCDR

191. Surgical site infections after cesarean delivery: epidemiology, prevention and treatment Full Text available with Trip Pro

Surgical site infections after cesarean delivery: epidemiology, prevention and treatment Cesarean delivery (CD) is one of the most common procedures performed in the United States, accounting for 32% of all deliveries. Postpartum surgical site infection (SSI), wound infection and endometritis is a major cause of prolonged hospital stay and poses a burden to the health care system. SSIs complicate a significant number of patients who undergo CD - 2-7% will experience sound infections and 2-16 (...) % will develop endometritis. Many risk factors for SSI have been described. These include maternal factors (such as tobacco use; limited prenatal care; obesity; corticosteroid use; nulliparity; twin gestations; and previous CD), intrapartum and operative factors (such as chorioamnionitis; premature rupture of membranes; prolonged rupture of membranes; prolonged labor, particularly prolonged second stage; large incision length; subcutaneous tissue thickness > 3 cm; subcutaneous hematoma; lack of antibiotic

2017 Maternal health, neonatology and perinatology

192. Bovine Endometrial Epithelial Cells Scale Their Pro-inflammatory Response In vitro to Pathogenic Trueperella pyogenes Isolated from the Bovine Uterus in a Strain-Specific Manner Full Text available with Trip Pro

Bovine Endometrial Epithelial Cells Scale Their Pro-inflammatory Response In vitro to Pathogenic Trueperella pyogenes Isolated from the Bovine Uterus in a Strain-Specific Manner Among different bacteria colonizing the bovine uterus, Trueperella pyogenes is found to be associated with clinical endometritis (CE). The ability of cows to defend against T. pyogenes infections depends on the virulence of invading bacteria and on the host's innate immunity. Therefore, to gain insights into bacterial (...) factors contributing to the interplay of this host pathogen, two strains of T. pyogenes were included in this study: one strain (TP2) was isolated from the uterus of a postpartum dairy cow developing CE and a second strain (TP5) was isolated from a uterus of a healthy cow. The two strains were compared in terms of their metabolic fingerprints, growth rate, virulence gene transcription, and effect on bovine endometrial epithelial cells in vitro. In addition, the effect of the presence of peripheral

2017 Frontiers in cellular and infection microbiology

193. Lidocaine for Pain Control During Intrauterine Device Insertion

of failed intrauterine device insertion (uterine perforation, acute expulsion). 3. Copper allergy. 4. Uterine anomaly. 5. Post-partum endometritis or septic abortion in the past three months. 6. Untreated cervicitis/vaginitis, including bacterial vaginosis. 7. Immunosuppression. 8. History of lidocaine ,prilocaine allergy. 9. Analgesic or anxiolytic use within the last 24 hours before the procedure. 10. Wilson's disease. 11. Suspicion of pregnancy. 12. Untreated abnormal uterine bleeding. Contacts (...) During Intrauterine Device Insertion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03362905 Recruitment Status : Not yet recruiting First Posted : December 5, 2017 Last Update Posted : December 5, 2017 See Sponsor: Ain

2017 Clinical Trials

194. Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean

review, whose onset is after randomization Postpartum infectious complications [ Time Frame: within 6 weeks postpartum ] Infectious complications such as: endometritis, surgical site infection, pelvic abscess Admission to the intensive care unit for more than 24 hours [ Time Frame: within 6 weeks postpartum ] Any admission to the intensive care unit that lasts more than 24 hours Maternal death [ Time Frame: within 6 weeks postpartum ] Use of uterotonics other than oxytocin [ Time Frame: within 48 (...) to lowest post-operative measured TXA side effects [ Time Frame: within 24 hours postpartum ] Maternal TXA-related side-effects (nausea, vomiting, dizziness) Open label use of TXA or other antifibrinolytic [ Time Frame: within 7 days postpartum ] Use of any amount of open-label TXA (not blinded study drug) or other antifibrinolytic (eg., Amicar) Length of stay [ Time Frame: Until hospital discharge, an average of 3 days ] Mother's length of stay from delivery to discharge Hospital re-admission [ Time

2017 Clinical Trials

195. Oxytocin Dosing at Planned Cesarean Section and Anemia

to Primary Outcome Measures : Blood loss in postpartum period defined by grams/hour [ Time Frame: 3-4 days after delivery ] Measure pads used post-partum Secondary Outcome Measures : Change in Hemoglobin [ Time Frame: 24 hours ] Pre-op hemoglobin and post-op hemoglobin Change in Hematocrit [ Time Frame: 24 hours ] Pre-op hematocrit and post-op hematocrit Length of hospital stay [ Time Frame: 3-4 days after delivery ] Start of surgery to discharge (hours) Need for additional uterotonics [ Time Frame: 24 (...) hours after delivery ] Use of uterotonics Continuation of breastfeeding [ Time Frame: 6 weeks ] Is patient breastfeeding at 6 week post-partum visit Quantity of narcotic pain medications [ Time Frame: 3-4 days after delivery ] Number of narcotic tablets used from time of surgery to discharge Attendance at post-partum visit [ Time Frame: 6 weeks ] Did patient attend post-partum visit? Post-partum complications [ Time Frame: 6 weeks ] Did patient have surgical wound infection, endometritis? Need

2017 Clinical Trials

196. Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries

of azithromycin, 1 gram of azithromycin+2 grams of amoxicillin or placebo. Women will be followed to ascertain maternal infectious outcomes and perinatal outcomes. Condition or disease Intervention/treatment Phase Postpartum Sepsis Postpartum Endometritis Postpartum Fever Drug: Azithromycin Drug: Azithromycin and amoxicillin Drug: Placebo Phase 4 Detailed Description: This 3-arm study is a large randomized clinical trial designed to evaluate the comparative effectiveness and safety of single dose oral (...) Identifier: Other Study ID Numbers: CHI UAB MISP # 54628 First Posted: August 14, 2017 Last Update Posted: February 20, 2019 Last Verified: February 2019 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Layout table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Additional relevant MeSH terms: Layout table for MeSH terms Sepsis Endometritis Puerperal Infection Infection Systemic Inflammatory Response

2017 Clinical Trials

197. Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery

Measures : Composite wound complication [ Time Frame: Four weeks postpartum ] Any of wound infection, seroma/hematoma, wound separation >1 cm, and wound dehiscence Secondary Outcome Measures : Patient survey [ Time Frame: Four weeks postpartum ] Through patient surveys administered prior to hospital discharge and at four weeks post-operative investigators will evaluate patient satisfaction with wound healing. Satisfactory measures will include how well participants think incision healed mobility after (...) of active phase, arrest of descent, malpresentation, repeat cesarean delivery, desired cesarean Reason for admission [ Time Frame: At the time of admission ] Spontaneous labor, rupture of membranes, induction of labor, scheduled cesarean delivery, fetal condition (oligohydroamnios, growth restriction, non reassuring fetal heart tracing) Labor duration [ Time Frame: At the time of cesarean delivery ] Endometritis [ Time Frame: Four weeks postpartum ] Length of rupture of membranes [ Time Frame

2017 Clinical Trials

198. Effects of subcutaneous calcium administration at calving on mineral status, health, and production of Holstein cows. Full Text available with Trip Pro

ratio was >1 for development of metritis, and clinical and subclinical endometritis in control cows relative to 2SC250 cows, which indicates a higher risk of developing disease for control cows (2.03, 1.7, and 1.8 times, respectively). These results suggest that prophylactic s.c. infusions of Ca at calving can improve postpartum Ca status in Holstein cows and intake at 1 DIM. Given the reduction of metritis, clinical and subclinical endometritis, and subclinical hypocalcemia with treatment (...) (9.27mg/dL), and 2SC250 (9.07mg/dL) was greater during the first week postpartum compared with control (8.45mg/dL). Serum concentrations of P, Mg, BHB, glucose, and milk yield were not affected by treatments. The dry matter intake during the first 24h after calving was higher for treatments 1SC250 (13.5kg), 1SC500 (15.0kg), and 2SC250 (15.6kg) relative to control (12.5kg). Milk somatic cell counts were lower for 1SC500 (90.5 cells/mL) and 2SC250 (82.2 cells/mL) than control (132.8 cells/mL). Risk

2017 Journal of dairy science Controlled trial quality: uncertain

199. Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women

in Fetal Growth Restriction of Uncomplicated Women (GROW) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03046355 Recruitment Status : Recruiting First Posted : February 8, 2017 Last Update Posted : July 17, 2017 See (...) Development The NICHD nomogram will indicate their birth weight percentile based on their gestational age and ethnicity Secondary Outcome Measures : Number of children presenting with CNM [ Time Frame: Up to 6 weeks after delivery ] Composite neo-natal morbidity (CNM) is any of the following: Apgar score <5 at 5 minutes, seizure, sepsis, hypoglycemia requiring intravenous treatment, mechanical ventilation, CPAP (continuous positive airway pressure) or high-flow nasal cannula for >2 hours, oxygen

2017 Clinical Trials

200. LCS16 vs. COC User Satisfaction and Tolerability Study

the Screening Visit) Infected abortion or postpartum endometritis within 3 months prior to the Screening Visit. Chronic, daily use of drugs that may increase serum potassium levels. Undiagnosed abnormal genital bleeding. Acute cervicitis or vaginitis (until successfully treated). Lower urinary tract infection (until successfully treated). Acute or recurrent pelvic inflammatory disease or conditions associated with increased risk for pelvic infections. Congenital or acquired uterine anomaly including (...) Study The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03074045 Recruitment Status : Active, not recruiting First Posted : March 8, 2017 Last Update Posted : March 6, 2019 Sponsor: Bayer Information provided by (Responsible Party): Bayer Study Details Study Description Go to Brief Summary: To evaluate

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>